365 related articles for article (PubMed ID: 25870369)
1. Blood pressure and adverse events during continuous flow left ventricular assist device support.
Saeed O; Jermyn R; Kargoli F; Madan S; Mannem S; Gunda S; Nucci C; Farooqui S; Hassan S; Mclarty A; Bloom M; Zolty R; Shin J; D'Alessandro D; Goldstein DJ; Patel SR
Circ Heart Fail; 2015 May; 8(3):551-6. PubMed ID: 25870369
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
3. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
[TBL] [Abstract][Full Text] [Related]
4. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
[TBL] [Abstract][Full Text] [Related]
5. Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications.
Fukuhara S; Takeda K; Chiuzan C; Han J; Polanco AR; Yuzefpolskaya M; Mancini DM; Colombo PC; Topkara VK; Kurlansky PA; Takayama H; Naka Y
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):201-9, 210.e1-2. PubMed ID: 26699773
[TBL] [Abstract][Full Text] [Related]
6. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
7. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
8. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
[TBL] [Abstract][Full Text] [Related]
9. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
11. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices.
Maltais S; Topilsky Y; Tchantchaleishvili V; McKellar SH; Durham LA; Joyce LD; Daly RC; Park SJ
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1370-6. PubMed ID: 21839483
[TBL] [Abstract][Full Text] [Related]
13. From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
Tarzia V; Di Giammarco G; Di Mauro M; Bortolussi G; Maccherini M; Tursi V; Maiani M; Bernazzali S; Marinelli D; Foschi M; Buratto E; Bejko J; Gregori D; Scuri S; Livi U; Sani G; Bottio T; Gerosa G
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):213-7. PubMed ID: 26548997
[TBL] [Abstract][Full Text] [Related]
14. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.
Han J; Takeda K; Takayama H; Kurlansky PA; Mauro CM; Colombo PC; Yuzefpolskaya M; Fukuhara S; Truby LK; Topkara VK; Garan AR; Mancini DM; Naka Y
J Thorac Cardiovasc Surg; 2016 Feb; 151(2):520-7.e1. PubMed ID: 26806510
[TBL] [Abstract][Full Text] [Related]
15. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients.
Jorde UP; Uriel N; Nahumi N; Bejar D; Gonzalez-Costello J; Thomas SS; Han J; Morrison KA; Jones S; Kodali S; Hahn RT; Shames S; Yuzefpolskaya M; Colombo P; Takayama H; Naka Y
Circ Heart Fail; 2014 Mar; 7(2):310-9. PubMed ID: 24415682
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency.
Retzer EM; Sayer GT; Fedson SE; Nathan S; Jeevanandam V; Friant J; Uriel N; Lang RM; Russo MJ; Shah AP
Catheter Cardiovasc Interv; 2016 Apr; 87(5):971-9. PubMed ID: 26527571
[TBL] [Abstract][Full Text] [Related]
20. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
